Cedar Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Cedar Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $4,892 - $5,352	12 New	12 $5,000
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $1,174 - $1,462	-5 Reduced 1.54%	319 $90,000
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $9,963 - $11,743	-45 Reduced 12.2%	324 $85,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $27,613 - $34,858	-156 Reduced 29.71%	369 $81,000
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $14,692 - $16,442	81 Added 18.24%	525 $95,000
Q2 2021 Aug 09, 2021	BUY	$187.49 - $221.1 $83,245 - $98,168	444 New	444 $90,000
Q3 2018 Nov 06, 2018	SELL	$167.73 - $192.74 $4,696 - $5,396	-28 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$145.72 - $169.96 $4,080 - $4,758	28 New	28 $5,000
Q4 2017 Feb 02, 2018	SELL	$137.28 - $155.55 $2,059 - $2,333	-15 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$148.13 - $162.24 $2,221 - $2,433	15	15 $2,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Cedar Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Wealth Management, LLC with notifications on news.